Theasaponin E₁ as an effective ingredient for anti-angiogenesis and anti-obesity effects

References

• Fujiki F, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, Kozu T, Tada Y, Suga K, Imai K. Cancer inhibition by green tea. Mutat. Res. 1998;402:307–310.10.1016/S0027-5107(97)00310-2
   PubMed Web of Science ®Google Scholar
• Lin JK, Lin-Shiau SY. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol. Nutr. Food. Res. 2006;50:211–217.10.1002/(ISSN)1613-4133
   PubMed Web of Science ®Google Scholar
• Moyers SB, Kumar NB. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr. Rev. 2004;62:204–211.10.1111/nure.2004.62.issue-5
   PubMed Web of Science ®Google Scholar
• Maria L, Urte L, Volker B, Roland B. Antioxidant properties and total phenolics content of green and black tea under different brewing conditions. Z. Lebensm Unters Forsch A. 1999;208:217–220.
   Google Scholar
• Kohata K, Yamauchi Y, Ujihara T, Horie H. Growth inhibitory activity of Tea-seeds Saponins and Glyphosate to Weed Seedlings. Japan Int. Res. Cent. Agric. Sci. 2004;38:267–270.
   Google Scholar
• Tomita M, Yamamoto S, Yamaguchi K, Ohigashi H, Yagi T, Kohata K, Berden JA. Theasaponin E1 destroys the salt tolerance of yeast. J. Biosci. Bioeng. 2000;90:637–642.
   PubMed Web of Science ®Google Scholar
• Sagesaka Y, Uemura T, Suzuki Y, Sugiura T, Yoshida M, Kyuki K. Antimicrobial and anti-inflammatory actions of tea-leaf saponin. Yakugaku Zasshi. 1996;116:238–243.
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Kato T, Kamada S, Yahata A. Three-month oral repeated administration toxicity study of seed saponins of Thea sinensis L. (Ryokucha saponin) in rats. Food Chem. Toxicol. 1994;32:431–442.10.1016/0278-6915(94)90041-8
   PubMed Web of Science ®Google Scholar
• Han LK, Kimura Y, Kawashima M, Takaku T, Taniyama T, Hayashi T, Zeng YN, Okuda H. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int. J. Obes. 2001;25:1459–1464.10.1038/sj.ijo.0801747
   PubMed Web of Science ®Google Scholar
• Cao Y. Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 2007;117:2362–2368.10.1172/JCI32239
   PubMed Web of Science ®Google Scholar
• Crandall DL, Hausman GJ, Kral JG. A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives. Microcirculation. 1997;4:211–232.10.3109/10739689709146786
   PubMed Web of Science ®Google Scholar
• Hausman GJ, Richardson RL. Adipose tissue angiogenesis. J. Anim. Sci. 2004;82:925–934.
   PubMed Web of Science ®Google Scholar
• Neels JG, Thinnes T, Loskutoff DJ. Angiogenesis in an in vivo model of adipose tissue development. FASEB J. 2004;18:983–985.
   PubMed Web of Science ®Google Scholar
• Voros G, Maquoi E, Demeullemeester D, Clerx N, Collen D, Lijnen HR. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology. 2005;146:4545–4554.10.1210/en.2005-0532
   PubMed Web of Science ®Google Scholar
• Christiaens V, Lijnen HR. Angiogenesis and development of adipose tissue. Mol. Cell. Endocrinol. 2010;318:2–9.10.1016/j.mce.2009.08.006
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis. Annu. Rev. Med. 2006;57:1–18.10.1146/annurev.med.57.121304.131306
   PubMed Web of Science ®Google Scholar
• Zetter BR. Angiogenesis and metastatis. Annu. Rev. Med. 1998;49:407–427.10.1146/annurev.med.49.1.407
   PubMed Web of Science ®Google Scholar
• Ferrara N. VEGF and the quest for tumor angiogenesis factors. Nat. Rev. Cancer. 2002;2:795–803.10.1038/nrc909
   PubMed Web of Science ®Google Scholar
• Olsson AK, Dimberg A, Kreuger J, Claesson-Weish L. VEGF receptor signalling—in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006;7:359–371.10.1038/nrm1911
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: From innocent bystander to major culprit. Nat. Rev. Cancer. 2002;2:301–310.10.1038/nrc780
   PubMed Web of Science ®Google Scholar
• Kitagawa I, Hori K, Motozawa T, Murakami T, Yoshikawa M. Structures of new acylated oleanene-type triterpene oligoglycosides, theasaponins E1 and E2, from the seeds of tea plant, Camellia sinensis (L.) O. Kuntze. Chem. Pharm. Bull. 1998;46:1901–1906.10.1248/cpb.46.1901
   PubMedGoogle Scholar
• Ramírez-Zacarías JL, Castro-Muñozledo F, Kuri-Harcuch K. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 1992;97:493–497.10.1007/BF00316069
   PubMedGoogle Scholar
• Glauert AM, Dingle JT, Lucy JA. Action of saponin on biological membranes. Nature. 1962;196:953–955.10.1038/196953a0
   Web of Science ®Google Scholar
• Go-gelein H, Huby A. Interaction of saponin and digitonin with black lipid membranes and lipid monolayers. Biochim. Biophys. Acta. 1984;773:32–38.10.1016/0005-2736(84)90547-9
   PubMed Web of Science ®Google Scholar
• Lamalice L, Boeuf FL, Huot J. Endothelial cell migration during angiogenesis. Circ. Res. 2007;100:782–794.10.1161/01.RES.0000259593.07661.1e
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, Zanetti A, Angellio A, Mattot V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D, Dejana E. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis. Cell. 1999;98:147–157.10.1016/S0092-8674(00)81010-7
   PubMed Web of Science ®Google Scholar
• Jeong J, Pise-Masison CA, Radonovich MF, Park HU, Brady JN. Activated Akt regulates NF-kB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene. 2005;24:6719–6728.10.1038/sj.onc.1208825
   PubMed Web of Science ®Google Scholar
• Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ, Dinney CP. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin. Cancer Res. 2003;9:2786–2797.
   PubMed Web of Science ®Google Scholar
• Duncan RE, El-Sohemy A, Archer MC. Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity. J. Biol. Chem. 2004;279:33079–33084.10.1074/jbc.M400732200
   PubMed Web of Science ®Google Scholar
• Li YC, Park MJ, Ye SK, Kim CW, Kim YN. Elevated Levels of Cholesterol-Rich Lipid Rafts in Cancer Cells Are Correlated with Apoptosis Sensitivity Induced by Cholesterol-Depleting Agents. Am. J. Pathol. 2006;168:1107–1118.10.2353/ajpath.2006.050959
   PubMed Web of Science ®Google Scholar
• Doldi N, Bassan M, Gulisano M, Broccoli V, Boncinelli E, Ferrari A. Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer. Gynecol. Endocrinol. 1996;10:375–382.10.3109/09513599609023600
   PubMed Web of Science ®Google Scholar